266 related articles for article (PubMed ID: 9973480)
1. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.
Itoh Y; Hemmer B; Martin R; Germain RN
J Immunol; 1999 Feb; 162(4):2073-80. PubMed ID: 9973480
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of lck and loss of TCR-mediated signaling upon persistent engagement with complexes of peptide:MHC molecules.
Lee JE; Cossoy MB; Chau LA; Singh B; Madrenas J
J Immunol; 1997 Jul; 159(1):61-9. PubMed ID: 9200439
[TBL] [Abstract][Full Text] [Related]
3. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand.
Abraham C; Griffith J; Miller J
J Immunol; 1999 Apr; 162(8):4399-405. PubMed ID: 10201975
[TBL] [Abstract][Full Text] [Related]
4. Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor.
Blichfeldt E; Munthe LA; Røtnes JS; Bogen B
Eur J Immunol; 1996 Dec; 26(12):2876-84. PubMed ID: 8977280
[TBL] [Abstract][Full Text] [Related]
5. The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
Hudrisier D; Kessler B; Valitutti S; Horvath C; Cerottini JC; Luescher IF
J Immunol; 1998 Jul; 161(2):553-62. PubMed ID: 9670927
[TBL] [Abstract][Full Text] [Related]
6. CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR.
Leitenberg D; Boutin Y; Constant S; Bottomly K
J Immunol; 1998 Aug; 161(3):1194-203. PubMed ID: 9686579
[TBL] [Abstract][Full Text] [Related]
7. Distinct biochemical signals characterize agonist- and altered peptide ligand-induced differentiation of naive CD4+ T cells into Th1 and Th2 subsets.
Boutin Y; Leitenberg D; Tao X; Bottomly K
J Immunol; 1997 Dec; 159(12):5802-9. PubMed ID: 9550376
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling.
Dorfman JR; Stefanová I; Yasutomo K; Germain RN
Nat Immunol; 2000 Oct; 1(4):329-35. PubMed ID: 11017105
[TBL] [Abstract][Full Text] [Related]
9. TCR ligand avidity determines the mode of B-Raf/Raf-1/ERK activation leading to the activation of human CD4+ T cell clone.
Tsukamoto H; Irie A; Chen YZ; Takeshita K; Kim JR; Nishimura Y
Eur J Immunol; 2006 Jul; 36(7):1926-37. PubMed ID: 16791876
[TBL] [Abstract][Full Text] [Related]
10. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
Chen YZ; Matsushita S; Nishimura Y
J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
[TBL] [Abstract][Full Text] [Related]
11. A role of kinase inactive ZAP-70 in altered peptide ligand stimulated T cell activation.
Kim JR; Irie A; Tsukamoto H; Nishimura Y
Biochem Biophys Res Commun; 2006 Mar; 341(1):19-27. PubMed ID: 16412387
[TBL] [Abstract][Full Text] [Related]
12. Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation.
Bachmann MF; Oxenius A; Speiser DE; Mariathasan S; Hengartner H; Zinkernagel RM; Ohashi PS
Eur J Immunol; 1997 Sep; 27(9):2195-203. PubMed ID: 9341759
[TBL] [Abstract][Full Text] [Related]
13. Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells.
Hemmer B; Stefanova I; Vergelli M; Germain RN; Martin R
J Immunol; 1998 Jun; 160(12):5807-14. PubMed ID: 9637491
[TBL] [Abstract][Full Text] [Related]
14. Serial triggering of many T-cell receptors by a few peptide-MHC complexes.
Valitutti S; Müller S; Cella M; Padovan E; Lanzavecchia A
Nature; 1995 May; 375(6527):148-51. PubMed ID: 7753171
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
[TBL] [Abstract][Full Text] [Related]
16. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
Frasca L; Del Porto P; Tuosto L; Marinari B; Scottà C; Carbonari M; Nicosia A; Piccolella E
J Immunol; 1999 Jul; 163(2):650-8. PubMed ID: 10395654
[TBL] [Abstract][Full Text] [Related]
17. Role of CD3gamma and CD3delta cytoplasmic domains in cytolytic T lymphocyte functions and TCR/CD3 down-modulation.
Luton F; Buferne M; Legendre V; Chauvet E; Boyer C; Schmitt-Verhulst AM
J Immunol; 1997 May; 158(9):4162-70. PubMed ID: 9126976
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol synthesis is a proximal event in intracellular signaling coupled to T cell receptor ligation. Differential induction by conventional antigen and retroviral superantigen.
Weber GF; Cantor H
J Immunol; 1994 May; 152(9):4433-43. PubMed ID: 7908918
[TBL] [Abstract][Full Text] [Related]
19. Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide.
Vessey SJ; Barouch DH; McAdam SN; Tussey LG; Davenport MA; O'Callaghan CA; Bell JI; McMichael AJ; Jakobsen BK
Eur J Immunol; 1997 Apr; 27(4):879-85. PubMed ID: 9130639
[TBL] [Abstract][Full Text] [Related]
20. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
Shier P; Ngo K; Fung-Leung WP
J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
